Looks like you’re on the UK site. Choose another location to see content specific to your location

Home Industry News Takeda publishes 2009 full-year results

Takeda publishes 2009 full-year results

13th May 2010

Takeda has published its financial breakdown for its 2009 fiscal year, which concluded on March 31st 2010.

The pharmaceutical company’s consolidated net sales for the 12-month period came to a total of 1.5 billion yen (10.5 million pounds), a decrease of 4.7 per cent compared to the previous year.

It attributed this fall to the appreciation of the yen against the euro and US dollar, while highlighting positive trends from the last year, including increased sales of its multiple myeloma treatment Velcade.

The firm was also able to achieve an increase in its consolidated operating income, thanks to its success in reducing expenses in areas such as administration and research and development.

It said: “We are working toward realization of Takeda’s management mission – which will ultimately lead the company to both mid and long-term growth and further returns to our stockholders.”

Last month, Takeda commenced a phase III clinical trial to determine the safety and efficacy of brentuximab vedotin, its new treatment for Hodgkin’s lymphoma.

We currently have 6 jobs available in Pharmacy industry, find your perfect one now.

Stay informed

Receive the latest industry news, Tips
and straight to your inbox.